Insights
Stay up to date on PsychoGenics’ latest research, press releases, and industry developments in preclinical drug discovery. Combine our expertise with yours to spark the translational power of your next CNS breakthrough.
POSTER
The NIH HEAL Initiative Preclinical Screening Platform for Pain Efforts to Validate Two Models of Chemotherapy-Induced Painful Neuropathy in the Rat
POSTER
Efforts to Accelerate Development of Non-Opioid, Non-Addictive Pain Therapeutics Within the NIH HEAL Initiative Preclinical Screening Platform for Pain and Validation Examples
POSTER
Characterization of the Rat MonoiodoacetateModel of Osteoarthritis: Evoked and Non-evoked Pain Response Assessments
POSTER
Characterization and optimization of rat models of osteoarthritis pain to profile novel assets in support of the NIH HEAL Initiative Preclinical Screening Platform for Pain (PSPP)
PUBLICATION
Immunotherapy Targeting the C-Terminal Domain of TDP-43 Decreases Neuropathology and Confers Neuroprotection in Mouse Models of ALS/FTD
PUBLICATION
The GBA1 D409V Mutation Exacerbates Synuclein Pathology to Differing Extents in two Alpha-Synuclein Models
PUBLICATION
Elevation of brain magnesium with Swiss chard and buckwheat extracts in an animal model of reduced magnesium dietary intake
WEBINAR
Molecular Biomarkers and Disease Markers at PsychoGenics [WEBINAR]
WEBINAR
